The Boston Type I Keratoprosthesis (BKPro)

The Boston Type I Keratoprosthesis (BKPro) is an artificial cornea designed to restore vision in patients with severe corneal blindness who are poor candidates for standard donor transplants. It consists of a front plate with a central optical stem, a donor corneal graft sandwiched between the plates, a back plate, and a titanium locking ring that holds the assembly together. BKPro was approved by the U.S. Food and Drug Administration in 1992 and has since become a widely accepted treatment for cases where penetrating keratoplasty has repeatedly failed or is unlikely to succeed PMCWikipedia.

Corneal blindness occurs when the clear front layer of the eye—called the cornea—becomes damaged or opaque, preventing light from entering and forming a clear image on the retina. Causes range from infections like herpes simplex keratitis to autoimmune diseases such as Stevens‑Johnson syndrome, chemical burns, and repeated graft failures after traditional corneal transplant surgery. Worldwide, corneal blindness affects millions, and in many cases, conventional corneal grafts are not successful due to severe inflammation, scarring, or poor healing of the ocular surface. In these situations, an artificial cornea, or “keratoprosthesis,” can restore vision by replacing the diseased cornea with a synthetic device.

The Boston Type I Keratoprosthesis (Boston KPro) is the most widely used artificial cornea globally. Developed at the Massachusetts Eye and Ear Infirmary, it received U.S. Food and Drug Administration approval in 1992 and has undergone several design improvements since. The Boston KPro is a collar‑button shape made of medical‑grade polymethyl methacrylate (PMMA) with a titanium locking ring. It integrates with a donor corneal button that is sutured into the patient’s eye, creating a clear optical channel. The result is often rapid visual rehabilitation, even in eyes that have failed multiple previous grafts.

Early keratoprosthesis attempts in the 19th and early 20th centuries were plagued by extrusion, infection, and glaucoma. In the late 1960s, Dr. Claes Dohlman pioneered a two‑piece design combining an optical core and a donor cornea skirt, reducing device rejection. Continuous refinements led to the Boston KPro’s current design: a central PMMA optic (3.0 mm diameter) and a surrounding PMMA back plate, held together by a titanium locking ring and assembled within a 0.25 mm–thick donor corneal graft. Recent iterations offer fenestrated back plates for nutrient flow and reduced risk of stromal thinning. The device’s modularity allows surgeons to choose between polymethyl methacrylate or titanium back plates for optimal biocompatibility.

How the Boston Type I Keratoprosthesis Works

Once implanted, the Boston KPro functions as a permanent, clear window that transmits light directly to the retina. The donor corneal tissue acts as a biologic carrier, promoting integration with the patient’s eye and minimizing extrusion. Nutrients and oxygen from tear film pass through microperforations in the back plate, sustaining the underlying tissues. Post‑operative care focuses on preventing infection, controlling inflammation, and managing intraocular pressure, since glaucoma is a common complication. With proper selection and lifelong follow‑up, over 70 percent of patients achieve best‑corrected visual acuity of 20/200 or better within months of surgery.

The device is machined from medical‑grade polymethylmethacrylate (PMMA) and comes “off the shelf” in pseudophakic power, with an option for a customized aphakic optic. Adult back plates measure 8.5 mm in diameter, while pediatric versions are 7.0 mm. During implantation, the BKPro is assembled around a donor graft and sutured into the eye similarly to a penetrating keratoplasty, providing a clear optical pathway where the patient’s native cornea is opaque Wikipediaengage.england.nhs.uk.

Types

There are two main variants of the Boston Keratoprosthesis: Type I and Type II. Type I is used when the eyelids, blink mechanism, and tear film are intact, and it is by far the most common format. Type II features a longer anterior nub that extends through a tarsorrhaphy and is reserved for patients with severe ocular surface disease and end‑stage dry eye. Within Type I, further subtypes include standard pseudophakic optics and customized aphakic optics, as well as adult (8.5 mm) and pediatric (7.0 mm) back‑plate sizes WikipediaBlueShieldCA.

Causes Leading to BKPro Consideration

1. Repeat Corneal Graft Failure
   When patients experience multiple failed penetrating keratoplasties due to immunologic rejection or graft melting, the prognosis for further donor grafts becomes poor. BKPro offers a mechanical solution that bypasses the need for viable donor tissue PMCWikipedia.

2. Chemical Injury
   Severe alkali or acid burns can destroy corneal limbal stem cells and lead to cicatricial changes. Traditional grafts often fail in these hostile environments, making BKPro a more reliable option for vision restoration PMCWikipedia.

3. Stevens–Johnson Syndrome
   This immune‑mediated mucocutaneous disease can cause scarring of the ocular surface and tear film deficiency. The inflammation and cicatrization resulting from Stevens–Johnson syndrome make conventional grafts prone to failure, whereas BKPro can provide durable clarity WikipediaWebEye.

4. Ocular Cicatricial Pemphigoid
   A chronic autoimmune condition targeting the conjunctival epithelium, ocular cicatricial pemphigoid leads to progressive scarring and symblepharon. Conjunctival biopsy with direct immunofluorescence is the gold standard for diagnosis, and BKPro can circumvent the compromised surface biology PMCEyeWiki.

5. Aniridia
   Congenital absence of the iris often accompanies limbal stem cell deficiency and nystagmus. Patients with aniridia have a high rate of graft failure, and BKPro has been shown to improve visual outcomes in these challenging cases PMCWikipedia.

6. Herpetic Keratitis
   Recurrence of herpes simplex virus in the cornea can lead to stromal scarring and neurotrophic changes. BKPro can be an effective treatment when antiviral therapy and repeat grafts fail to maintain graft clarity PMCWikipedia.

7. Neurotrophic Keratitis
   Damage to trigeminal nerve fibers reduces corneal sensation and impairs healing, leading to persistent epithelial defects. BKPro implantation can restore vision in neurotrophic corneas where traditional grafts repeatedly break down PMCWikipedia.

8. Extensive Corneal Neovascularization
   Blood vessel ingrowth into the cornea, from infections or inflammation, increases rejection risk for donor grafts. BKPro’s inert materials resist neovascular invasion, offering a clearer optical medium PMCWikipedia.

9. Severe Ocular Surface Disease
   Conditions like ocular rosacea or severe dry eye can compromise graft survival. BKPro bypasses the need for a healthy epithelial surface, providing a stable optical interface PMCWikipedia.

10. Corneal Perforation
    Traumatic or infectious perforations that create a full‑thickness defect may be managed initially with tectonic grafts; when these fail, BKPro offers a definitive solution PMCCleveland Clinic.

11. Thermal Injury
    High‑temperature burns from sparks or scalds can scar the cornea deeply. BKPro can restore vision where scarring precludes clear biological grafts WebEyeWikipedia.

12. Congenital Corneal Opacities
    Dystrophies such as Peters anomaly or sclerocornea present at birth. After multiple failed graft attempts, BKPro can be a viable alternative for these pediatric cases Wikipediaaes.amegroups.org.

13. Autoimmune Keratitis
    Rheumatoid arthritis and other systemic autoimmune diseases can inflame and scar the cornea. BKPro can maintain optical clarity in eyes prone to recurrent inflammation PMCWikipedia.

14. Chemical Conjunctivitis Sequalae
    Chronic inflammation of conjunctiva after chemical exposure can lead to symblepharon and keratinization. BKPro can bypass unusable ocular surfaces to restore vision WikipediaWebEye.

15. Hypotony and Glaucoma‑Related Edema
    Low intraocular pressure or glaucoma drainage devices can cause corneal decompensation. BKPro can survive in eyes with challenging pressure profiles and provide optical rehabilitation PMCWikipedia.

Symptoms Leading to Consideration of BKPro

1. Severe Vision Loss
   Progressive corneal opacification causes gradual or sudden loss of visual acuity, often to counting‑finger or worse levels, prompting consideration of BKPro when standard grafts fail Cleveland ClinicWebMD.

2. Photophobia
   Patients often complain of intense light sensitivity due to irregular corneal surfaces scattering light, which BKPro’s smooth optic surface can alleviate Cleveland ClinicWebMD.

3. Eye Pain
   Chronic epithelial defects or stromal thinning cause aching or sharp pain. BKPro can seal defects and reduce nociceptive stimuli Cleveland ClinicCureus.

4. Redness and Irritation
   Persistent conjunctival injection and inflammation often accompany surface disease. While BKPro does not treat underlying inflammation, it can clear vision and improve comfort by stabilizing the surface Cleveland ClinicWebMD.

5. Excessive Tearing
   Reflex tearing from dryness or epitheliopathy can be severe. BKPro reduces surface instability that triggers tearing PMCCleveland Clinic.

6. Foreign Body Sensation
   Disrupted surface epithelium can feel like grit; the prosthesis restores a smooth interface Cleveland ClinicWebMD.

7. Halos and Glare
   Irregular corneal optics cause diffraction rings around lights. BKPro’s polished optic minimizes these visual disturbances Cleveland ClinicCureus.

8. Recurrent Ulceration
   Patients with neurotrophic or autoimmune keratitis may develop repeated corneal ulcers; BKPro seals and protects the cornea from further breakdown Cleveland ClinicWebEye.

9. Corneal Perforation Risk
   Areas of severe thinning may risk spontaneous perforation; BKPro provides mechanical strength and integrity EBAACleveland Clinic.

10. Chronically Cloudy Vision
    Even mild but persistent haze from scarring or neovascularization can reduce contrast sensitivity; BKPro offers a clear optical medium Cleveland ClinicWebMD.

Diagnostic Tests

Physical Exam

1. Visual Acuity Test
   Measures the smallest letters a patient can read on a standardized chart, typically the Snellen chart at 20 feet, providing a baseline for treatment efficacy Cleveland ClinicWikipedia.

2. Slit‑Lamp Biomicroscopy
   A high‑intensity beam illuminates the cornea and anterior segment, revealing epithelial defects, stromal scars, and device positioning post‑BKPro Wikipedia.

3. Intraocular Pressure Measurement
   Tonometry (Goldmann or pneumatic) assesses pressure to rule out hypotony or glaucoma contributing to corneal edema PMC.

4. Pupil Reactivity Assessment
   Checks for afferent pupillary defects indicating optic nerve or retinal pathology that may limit visual improvement with BKPro PMC.

5. Extraocular Motility Testing
   Ensures full globe movement and rules out restrictive conditions that might complicate implantation PMC.

Manual Tests

6. Schirmer’s Test
   Filter paper strips in the lower fornix measure basal tear production over five minutes, diagnosing aqueous‑deficient dry eye Mount Sinai Health SystemWikipedia.

7. Tear Break‑Up Time (TBUT)
   Fluorescein dye instilled into the tear film under cobalt blue light measures the interval until the first dry spot appears, indicating tear film instability WikipediaWebEye.

8. Fluorescein Staining
   Dye application and blue‑light illumination reveal corneal epithelial defects and device‑cornea interface integrity MedlinePlusWebEye.

Lab and Pathological Tests

9. Corneal Scraping Culture
   Sterile scrapings plated on blood and Sabouraud agar identify bacterial, fungal, or protozoal pathogens in infectious keratitis PMCBCEye.

10. Conjunctival Biopsy with Direct Immunofluorescence
    Gold standard for diagnosing ocular cicatricial pemphigoid, revealing linear IgG and C3 deposits along the basement membrane PMCEyeWiki.

11. Tear Cytokine Analysis
    Magnetic bead assays quantify inflammatory mediators (e.g., IL‑6, IL‑8, IFN‑γ) to characterize ocular surface inflammation severity PMCPMC.

12. Genetic Testing for Corneal Dystrophies
    DNA analysis identifies mutations in genes such as TGFBI, guiding diagnosis of conditions like lattice or granular dystrophy aes.amegroups.orgWikipedia.

Electrodiagnostic Tests

13. Electroretinography (ERG)
    Measures retinal rod and cone function to ensure posterior segment viability before BKPro surgery PMCWikipedia.

14. Visual Evoked Potential (VEP)
    Assesses optic nerve conduction by recording cortical responses to visual stimuli, predicting visual potential post‑implant PMCaes.amegroups.org.

15. Electro‑oculography (EOG)
    Evaluates retinal pigment epithelial function and photoreceptor health, complementing ERG findings PMCaes.amegroups.org.

Imaging Tests

16. Anterior Segment Optical Coherence Tomography (OCT)
    High‑resolution cross‑sectional imaging shows device position, graft thickness, and periprosthetic corneal health WebEyeaes.amegroups.org.

17. Ultrasound Biomicroscopy
    Ultrasound imaging visualizes the anterior segment behind opaque media, assessing device seating and peripheral corneal anatomy PMCWebEye.

18. Specular Microscopy
    Evaluates corneal endothelial cell density and morphology to predict graft survival potential aes.amegroups.orgWikipedia.

19. Confocal Microscopy
    In vivo cellular‑level imaging detects microstructural changes around the prosthesis and monitors microbial invasion PMCWebEye.

20. B‑Scan Ultrasonography
    Posterior segment ultrasound rules out vitreoretinal pathology when corneal opacity precludes direct visualization PMCWikipedia.

Non‑Pharmacological Treatments

Non‑drug therapies play a vital role in optimizing ocular surface health, enhancing visual function, and improving patients’ quality of life before and after Boston KPro implantation. These treatments fall into three categories: Exercise Therapies, Mind‑Body Approaches, and Educational Self‑Management.

Exercise Therapies

1. Eye Movement Training
   Eye movement training focuses on improving coordination between both eyes. Through guided exercises—such as following a moving target horizontally and vertically—patients enhance oculomotor control, reduce visual fatigue, and optimize tracking of objects. The purpose is to stabilize vision and reduce oscillopsia (illusion of movement). Mechanistically, these exercises strengthen extraocular muscles and improve neural pathways controlling eye alignment.

2. Saccadic Fixation Exercises
   Saccades are rapid eye jumps used when scanning a page or scene. Patients practice jumping their gaze between two fixed points, gradually increasing speed and precision. This exercise enhances reading speed, visual search efficiency, and overall visual acuity. By repeatedly triggering burst neurons in the brainstem, saccadic training refines motor commands and sensory feedback loops.

3. Pursuit Movement Drills
   Smooth pursuit exercises involve following a slow‑moving object without shifting the head. These drills improve the continuous tracking of moving targets—like watching passing cars. The purpose is to enhance fluid retinal image registration, important for tasks like watching television or navigating busy environments. Physiologically, pursuit training enhances cortical processing in the frontal eye fields and cerebellum.

4. Contrast Sensitivity Rehabilitation
   Patients engage with visual stimuli of varying gray‑scale contrasts, gradually challenging the eye’s ability to distinguish subtle differences. This therapy improves low‑contrast vision essential for night driving and facial recognition. Repeated exposure enhances neural adaptation in the visual cortex, improving contrast detection thresholds.

5. Eccentric Viewing Training
   For those with central visual field defects, eccentric viewing teaches patients to use a healthier peripheral retinal locus. Through practice shifting fixation to off‑center points, patients learn new “preferred retinal loci” for reading and detailed tasks. This approach adapts cortical remapping, allowing the brain to process inputs from peripheral retina areas more effectively.

6. Orientation and Mobility Drills
   Low‑vision orientation exercises involve navigating structured environments with varying obstacles. Patients practice walking with a mobility cane or using tactile markers. The purpose is to build confidence in safe ambulation and spatial awareness. Mechanistically, these drills retrain visuospatial integration centers in the parietal lobe.

7. Reading Enhancement Therapy
   Using large‑print materials and adaptive reading devices, patients perform guided reading sessions to increase reading speed and comprehension. Exercises include tracking lines with a guiding ruler and progressively reducing font sizes. This therapy stimulates neuroplasticity in language and visual areas, reinforcing reading circuits.

8. Low‑Vision Rehabilitation Aids Training
   Under the guidance of a low‑vision specialist, patients learn to use devices like handheld magnifiers, video magnification systems, and closed‑circuit televisions. Training covers positioning, focus adjustment, and environmental lighting optimization. The purpose is to maximize remaining vision and independence. Repeated use solidifies sensorimotor coordination for device handling.

Mind‑Body Approaches

9. Mindfulness Meditation
   Mindfulness teaches patients to observe ocular discomfort and visual disturbances without judgment. Daily sessions of breathing awareness reduce anxiety and perceived eye strain. This practice down‑regulates the sympathetic nervous system, lowering stress‑induced inflammation that can exacerbate ocular surface disease.

10. Guided Imagery
    Through audio‑recorded scripts, patients visualize healing light bathing the eye, promoting relaxation and positive coping. Guided imagery enhances immune modulation via the hypothalamic‑pituitary‑adrenal axis, supporting tissue repair and reducing pro‑inflammatory cytokines.

11. Cognitive Behavioral Therapy (CBT)
    CBT addresses negative thoughts about vision loss by restructuring beliefs and developing coping strategies. In structured sessions, patients learn to challenge catastrophic thinking and adopt problem‑solving skills. This reduces depression and improves treatment adherence through enhanced self‑efficacy.

12. Biofeedback
    With feedback sensors measuring skin temperature or muscle tension, patients learn to consciously relax periocular muscles. Lowered muscle tension reduces blinking irregularities and improves tear film stability. Neurofeedback also modulates cortical areas linked to stress responses, promoting ocular surface homeostasis.

13. Progressive Muscle Relaxation
    Guided tensing and relaxing of facial and neck muscles relieve tension around the eyes. This reduces sympathetic overactivity and improves tear film distribution by encouraging more regular blinking patterns.

14. Stress Management Workshops
    Group sessions teach time management, relaxation breathing, and lifestyle adjustments to lower chronic stress. Reduced cortisol levels correlate with improved ocular surface healing and decreased risk of complications after KPro surgery.

Educational Self‑Management

15. Patient Education Workshops
    Structured classes led by ophthalmologists explain disease mechanisms, device care, and warning signs of complications. Well‑informed patients demonstrate higher adherence to drop regimens and follow‑up schedules, reducing complication rates.

16. Self‑Monitoring Logs
    Patients record daily vision checks, drop schedules, and symptom diaries. This practice improves early detection of redness or discharge, prompting timely medical review. Tracking visual acuity fluctuations enhances clinician decision‑making.

17. Symptom Diary Maintenance
    In a dedicated notebook or app, patients note pain, light sensitivity, and comfort levels. Reviewing trends enables personalized adjustments in therapy and encourages proactive management of ocular surface health.

18. Adherence Training
    Using pillboxes, alarms, and caregiver support, patients learn techniques to avoid missed doses of eye drops. Improved adherence correlates with lower infection rates and better long‑term outcomes.

19. Support Group Participation
    Online or in‑person meetings with other KPro recipients foster emotional support, exchange of practical tips, and shared experiences. Peer networks enhance motivation for self‑care and reduce feelings of isolation.

20. Telemedicine Follow‑Up
    Virtual check‑ins allow remote monitoring of ocular health through video exams and symptom reports. Early detection of issues—such as early signs of device extrusion—enables prompt intervention and reduces travel burdens for patients with limited mobility.

---

Essential Medications

After Boston KPro implantation, a lifelong medication regimen guards against infection, inflammation, and glaucoma. Below are ten evidence‑based drugs commonly used:

1. Vancomycin 14 mg/mL Eye Drops (Antibiotic)
   Dosage: One drop once daily (QD).
   Purpose: Prevents Gram‑positive bacterial infections, especially methicillin‑resistant Staphylococcus aureus.
   Mechanism: Inhibits bacterial cell wall synthesis by binding D‑alanine residues.

2. Moxifloxacin 0.5% Eye Drops (Fluoroquinolone Antibiotic)
   Dosage: One drop QD at night.
   Purpose: Broad‑spectrum coverage against Gram‑negative and some Gram‑positive bacteria.
   Mechanism: Inhibits bacterial DNA gyrase and topoisomerase IV, preventing replication.

3. Prednisolone Acetate 1% Eye Drops (Corticosteroid)
   Dosage: One drop four times daily (QID), tapering over months.
   Purpose: Controls postoperative inflammation and reduces scarring.
   Mechanism: Modulates gene expression to suppress inflammatory cytokines and cell migration.

4. Loteprednol Etabonate 0.5% Eye Drops (Soft Steroid)
   Dosage: One drop QID.
   Purpose: Low‑intraocular‑pressure steroid option for chronic inflammation.
   Mechanism: Similar anti‑inflammatory action with rapid metabolism to inactive metabolites, reducing steroid‑induced glaucoma risk.

5. Timolol Maleate 0.5% Eye Drops (Beta‑Blocker)
   Dosage: One drop twice daily (BID).
   Purpose: Manages postoperative intraocular pressure elevation.
   Mechanism: Reduces aqueous humor production by blocking β‑adrenergic receptors in the ciliary body.

6. Dorzolamide 2% Eye Drops (Carbonic Anhydrase Inhibitor)
   Dosage: One drop TID (three times daily).
   Purpose: Adds further IOP control when beta‑blockers alone are insufficient.
   Mechanism: Inhibits carbonic anhydrase II in the ciliary epithelium, decreasing aqueous secretion.

7. Brimonidine Tartrate 0.2% Eye Drops (Alpha‑2 Agonist)
   Dosage: One drop BID.
   Purpose: Adjunctive therapy for stubborn high IOP.
   Mechanism: Stimulates α₂‑adrenergic receptors, reducing aqueous production and increasing uveoscleral outflow.

8. Cyclosporine A 0.05% Eye Drops (Immunomodulator)
   Dosage: One drop BID.
   Purpose: Manages chronic surface inflammation and dry eye, enhancing tear production.
   Mechanism: Inhibits calcineurin, blocking T‑cell activation and pro‑inflammatory cytokine release.

9. Lifitegrast 5% Eye Drops (Lymphocyte Function‑Associated Antigen‑1 Antagonist)
   Dosage: One drop BID.
   Purpose: Alleviates ocular surface inflammation and discomfort in dry eye.
   Mechanism: Blocks LFA‑1/ICAM‑1 interaction, reducing T‑cell‑mediated inflammation.

10. Tacrolimus 0.03% Eye Ointment (Calcineurin Inhibitor)
    Dosage: Apply a thin strip to the ocular surface at bedtime.
    Purpose: Alternative immunosuppressive option for recalcitrant surface inflammation.
    Mechanism: Inhibits T‑cell activation by binding FK506‑binding protein, preventing cytokine gene transcription.

---

Dietary Molecular Supplements

Supporting ocular surface health with targeted nutrients can enhance tissue healing and reduce inflammation:

1. Omega‑3 Fish Oil
   Dosage: 1,000 mg daily.
   Function: Anti‑inflammatory precursor for resolvins and protectins.
   Mechanism: Converts to eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), down‑regulating pro‑inflammatory mediators.

2. Vitamin A (Retinol)
   Dosage: 10,000 IU daily.
   Function: Maintains conjunctival goblet cells and mucin production.
   Mechanism: Binds retinoic acid receptors to regulate epithelial differentiation and mucin gene expression.

3. Vitamin C (Ascorbic Acid)
   Dosage: 500 mg twice daily.
   Function: Collagen synthesis co‑factor, antioxidant defense.
   Mechanism: Recycles oxidized vitamin E and scavenges free radicals, protecting corneal stroma.

4. Vitamin E (α‑Tocopherol)
   Dosage: 400 IU daily.
   Function: Lipid membrane antioxidant.
   Mechanism: Donates electrons to lipid peroxyl radicals, interrupting free‑radical chain reactions.

5. Lutein
   Dosage: 10 mg daily.
   Function: Filters blue light, reduces oxidative stress.
   Mechanism: Accumulates in retinal and corneal tissues, absorbing high‑energy light.

6. Zeaxanthin
   Dosage: 2 mg daily.
   Function: Companion xanthophyll to lutein, enhances antioxidant capacity.
   Mechanism: Localizes in macular and corneal epithelium, quenching singlet oxygen.

7. Curcumin (Turmeric Extract)
   Dosage: 500 mg twice daily.
   Function: Broad‑spectrum anti‑inflammatory.
   Mechanism: Inhibits NF‑κB activation and COX‑2 expression, reducing cytokine release.

8. N‑Acetylcysteine (NAC)
   Dosage: 600 mg twice daily.
   Function: Mucolytic and antioxidant.
   Mechanism: Replenishes intracellular glutathione and breaks disulfide bonds in mucin, improving tear film fluidity.

9. Collagen Peptides
   Dosage: 10 g daily in water.
   Function: Supports stromal regeneration and epithelial healing.
   Mechanism: Provides hydroxyproline‑rich amino acids for collagen fibrillogenesis.

10. Bilberry Extract
    Dosage: 160 mg twice daily.
    Function: Anthocyanin‑rich antioxidant supporting microvascular health.
    Mechanism: Enhances capillary resistance and reduces lipid peroxidation in ocular tissues.

---

Regenerative and Stem Cell‑Based Therapies

Emerging biologic drugs aim to restore ocular surface cells or deliver growth factors:

1. Cenegermin (Recombinant Human Nerve Growth Factor)
   Dosage: 20 µg/mL eye drops, one drop QID for eight weeks.
   Function: Promotes corneal nerve regeneration and epithelial healing.
   Mechanism: Binds TrkA receptors on corneal nerves, stimulating axonal growth and neurotrophic support.

2. Recombinant Human Epidermal Growth Factor (rhEGF)
   Dosage: 10 µg/mL eye drops, one drop QID for four weeks.
   Function: Accelerates epithelial cell proliferation and wound closure.
   Mechanism: Activates EGFR signaling, up‑regulating genes involved in cell migration and division.

3. Regenerating Agent (RGTA®, Cacicol®)
   Dosage: 0.1% solution, one drop every other day for one month.
   Function: Mimics heparan sulfate, protecting growth factors and extracellular matrix.
   Mechanism: Binds and stabilizes endogenous growth factors, promoting matrix remodeling and epithelial adhesion.

4. Autologous Serum Eye Drops (20%)
   Dosage: Four times daily, prepared from patient’s blood.
   Function: Provides native growth factors (EGF, fibronectin) and vitamins.
   Mechanism: Delivers proteins and cytokines in physiologic ratios, supporting epithelial cell health.

5. Platelet‑Rich Plasma (PRP) Eye Drops
   Dosage: QID for one month.
   Function: High concentration of platelet‑derived growth factor and TGF‑β accelerates healing.
   Mechanism: Releases α‑granule growth factors that stimulate cell migration, angiogenesis, and extracellular matrix synthesis.

6. Mesenchymal Stem Cell Injections
   Dosage: 1 × 10⁶ cells via subconjunctival injection monthly for three months.
   Function: Immunomodulation and secretion of trophic factors for tissue repair.
   Mechanism: MSCs home to injured ocular surfaces, releasing exosomes with anti‑inflammatory and pro‑regenerative signals.

---

Additional Surgical Options

While Boston KPro is a key solution, other surgeries can optimize outcomes or address complications:

1. Limbal Stem Cell Transplantation
   Surgeons harvest healthy limbal tissue (from the patient or donor) and graft it onto the diseased cornea. This restores the native epithelial stem cell population, essential for corneal surface renewal. Benefits include long‑term epithelial stability and reduced risk of conjunctival overgrowth.

2. Amniotic Membrane Transplantation
   A cryopreserved amniotic membrane is sutured over the corneal surface to promote healing. It delivers anti‑inflammatory growth factors and provides a scaffold for epithelial cell migration. Patients experience reduced pain, inflammation, and scarring.

3. Tarsorrhaphy (Partial Eyelid Closure)
   Suturing part of the upper and lower eyelids reduces the exposed ocular surface, preserving moisture and protecting the keratoprosthesis from drying. It benefits patients with severe exposure or lagophthalmos by improving tear film stability.

4. Glaucoma Drainage Device Surgery
   A tube shunt (e.g., Ahmed or Baerveldt device) is implanted to divert aqueous humor from the anterior chamber to a subconjunctival reservoir. This effectively controls stubborn intraocular pressure elevation, reducing the risk of optic nerve damage.

5. Cataract Extraction with Posterior Chamber Intraocular Lens (IOL)
   In eyes with preexisting or coexisting cataracts, phacoemulsification and IOL implantation can be performed either before or after KPro surgery. This restores refractive clarity and improves overall visual outcomes.

---

 Prevention Strategies

1. Wear polycarbonate safety glasses during activities with debris risk to prevent corneal injury.

2. Promptly treat any eye infection with physician‑prescribed antibiotics to avoid permanent scarring.

3. Avoid exposure to harsh chemicals; use protective gloves and eye shields when handling irritants.

4. Manage autoimmune diseases (e.g., rheumatoid arthritis) under specialist care to reduce ocular surface inflammation.

5. Maintain meticulous eyelid hygiene to prevent blepharitis and secondary keratitis.

6. Use preservative‑free artificial tears if needing frequent lubrication, minimizing toxic preservative build‑up.

7. Schedule routine eye exams every three to six months for early detection of elevated intraocular pressure.

8. Avoid smoking and secondhand smoke, as tobacco toxins worsen dry eye and surface inflammation.

9. Protect eyes from UV damage by wearing sunglasses with UV‑blocking lenses outdoors.

10. Follow a balanced diet rich in antioxidants and omega‑3 fatty acids to support ocular surface health.

---

When to See a Doctor

Even with optimal care, Boston KPro patients may face complications. Seek immediate medical attention if you experience any of the following:

• Sudden vision loss or a significant decrease in visual clarity.

• Intense eye pain, especially if accompanied by redness or discharge.

• Visible device movement or partial extrusion of the prosthesis.

• Severe headache or eye nausea when lifting or bending (possible high eye pressure).

• Signs of infection, such as yellow or green discharge, swelling, or fever.

Prompt evaluation helps prevent irreversible damage and preserves visual function.

---

Guidelines: What to Do and What to Avoid

1. Do apply all eye drops on the prescribed schedule, ideally with reminders or alarms. Avoid missing doses, as lapses can increase infection and inflammation risks.

2. Do wear your plastic eye shield at night to prevent accidental rubbing. Avoid sleeping without protection, which may lead to device dislocation.

3. Do maintain good hand hygiene before administering drops. Avoid touching the eye or dropper tip to prevent contamination.

4. Do keep follow‑up appointments even if your vision seems stable. Avoid skipping visits, since early complications can be asymptomatic.

5. Do use a moisture chamber or humidifier in dry environments. Avoid exposing your eyes to direct air currents from fans or air conditioners.

6. Do clean your eyeglasses and shield regularly with mild soap and water. Avoid using harsh chemicals or rough cloths that could harbor bacteria.

7. Do wear UV‑blocking sunglasses outdoors, even on cloudy days. Avoid prolonged sun exposure without protection, which can damage the ocular surface.

8. Do notify your surgeon before any other eye surgery or dental procedure. Avoid unapproved procedures that may disrupt the prosthesis or introduce infection.

9. Do adopt stress‑reduction techniques, such as deep breathing or mindfulness. Avoid excessive physical strain or heavy lifting immediately after surgery.

10. Do maintain a healthy diet and hydration to support tear film production. Avoid high‑salt, dehydrating foods and excessive caffeine that can worsen dryness.

---

Frequently Asked Questions

1. What is the Boston Type I Keratoprosthesis?
   The Boston KPro is an artificial cornea made of PMMA and titanium, designed to replace a diseased cornea when standard transplants fail. It restores vision by providing a clear optical channel, with a donor corneal button acting as a biologic carrier.

2. Who qualifies for a Boston KPro implant?
   Candidates include patients with multiple failed corneal grafts, severe surface diseases like Stevens‑Johnson syndrome, chemical burns, or neurotrophic keratitis. A thorough evaluation of ocular surface health, tear production, and eyelid function is required.

3. How long does the Boston KPro last?
   With proper care, the device can function for decades. Long‑term studies show over 60 percent survival at five years. Lifelong follow‑up and adherence to medication are critical to prevent complications.

4. What are the main risks and complications?
   Common issues include glaucoma (increased eye pressure), retroprosthetic membrane formation, infection around the device, and corneal melt. Early detection and prompt treatment—often with laser, medication, or additional surgery—help manage these risks.

5. How soon can I see after surgery?
   Many patients notice vision improvement within days to weeks post‑implantation. However, final visual rehabilitation may take several months, depending on preexisting conditions and complication management.

6. Is the procedure painful?
   Surgery is performed under anesthesia, so there is no pain during the operation. Post‑operative discomfort—such as mild soreness or foreign body sensation—is usually managed with topical anesthetics and oral pain relievers.

7. What follow‑up care is required?
   Lifelong visits are necessary. Initially, patients are seen weekly, then monthly, and eventually every three to six months, depending on stability. Follow‑ups include visual acuity checks, IOP measurement, and slit‑lamp examination of the device.

8. Can I wear contact lenses or glasses afterward?
   Most patients need supplemental glasses for reading or to correct residual refractive error. Contact lenses are generally not used because of the artificial cornea design, though specialized bandage lenses may be fitted temporarily.

9. How much does it cost?
   Costs vary by country, hospital, and insurance coverage. In the United States, the device plus surgery can range from $20,000 to $40,000. Many patients obtain partial reimbursement through health insurance or government programs.

10. Can I travel by airplane?
    Yes, but take precautions: carry your medications in hand luggage, keep your eye shield on during sleep, and use lubricating drops more frequently in the dry cabin air.

11. Will I need systemic antibiotics?
    Systemic antibiotics are not routinely used unless there is a high risk of infection. Post‑operative care focuses on topical antibiotics to minimize systemic side effects.

12. Can I use makeup or artificial tears brands?
    Use preservative‑free artificial tears only. Avoid eye makeup that can flake and contaminate the device. If makeup is essential, apply carefully without touching the ocular surface.

13. Is vision with Boston KPro as clear as a natural cornea?
    Many patients achieve vision better than 20/200, with some reaching 20/40 or better. However, side effects like glare or halos may occur. Regular check‑ups help optimize visual function.

14. What if the device becomes loose or extrudes?
    Partial extrusion requires urgent evaluation. Minor loosening may be managed with resuturing, while complete extrusion often necessitates device removal and replacement.

15. Can children receive a Boston KPro?
    Pediatric use is limited and carries higher risks due to eye growth and behavior. In select cases with no alternatives, experienced centers may perform the procedure, emphasizing meticulous follow‑up and caregiver involvement.

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: July 15, 2025.